Bioethics

  • Home
  • About
  • Events
  • Bioethics Resources
    • Featured Articles
    • Academic Programs & Certificates
    • Bioethics Centers & Institutions
    • Bioethics Journals & Publications
    • Multimedia Resources
    • Bioethics 101 Resources
    • Book Reviews
    • Movie Reviews
    • Employment, Fellowships & Internships
  • Topics

Your global information source on bioethics news, issues, & events

  • Twitter
  • RSS
  • Artificial Intelligence
  • Biotech
  • Clinical / Medical
  • Cloning
  • Covid-19
  • Culture
  • Disability Ethics
  • Disaster Ethics
  • Education
  • Emerging Technologies
  • Employment / Fellowships / Internships
  • End of Life
  • Eugenics
  • Euthanasia / Suicide
  • Genetic Ethics
  • Geriatric & Aging
  • Global Bioethics
  • Healthcare
  • Human Dignity
  • Human Enhancement
  • Informed Consent
  • Journal Articles
  • Medical Tourism
  • Mental Health
  • Multimedia Resources
  • Nanotechnology
  • Neuroethics
  • Nursing
  • Organ Donation / Transplantation
  • Pediatric
  • Pharma
  • Public Health
  • Public Policy
  • Reproductive Ethics
  • Research Ethics
  • Reviews
  • Stem Cell Research
  • Synthetic Biology
  • Women's Health
Pharma

Pharma

March 14, 2024

Study: Gilead Antiviral Drug Shows Promise as a Treatment for Ebola Sudan

(STAT News) – A new study suggests the antiviral drug obeldesivir may be effective in curing Ebola Sudan infections, for which there are currently no approved vaccines or treatments. Scientists at the University of Texas Medical Branch in Galveston tested … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, News, Pharma



 
 

March 14, 2024

Fungal Diseases Are Spreading Undetected

(Nature) – India’s experience with mucormycosis reflects a broader diagnostic predicament: many low- and middle-income countries (LMICs) lack even the most basic tools for detecting the fungal diseases that kill an estimated 2.5 million people each year. Misdiagnosis often leads … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, highlights, News, Pharma, Public Health



 
 

March 13, 2024

Rigid Rules at Methadone Clinics Are Jeopardizing Patients’ Path to Recovery from Opioid Addiction

(STAT News) – As she predicted, Smith was forced to choose her medication over her job. Within weeks, she was late on rent for the apartment she’s lived in for over a decade. In the ensuing three months, Smith dutifully … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pharma, Public Health



 
 

March 12, 2024

Children to Stop Getting Puberty Blockers at Gender Identity Clinics, Say NHS England

(The Guardian) – Children who have gender dysphoria will no longer be given puberty blockers, NHS England has said, ahead of a radical change in how it cares for them. There is not enough evidence about either how safe they … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, Mental Health, News, Pediatric, Pharma, Reproductive Ethics



 
 

March 11, 2024

Experts Say Leaked Messages Present False Link Between Gender-Affirming Care and Cancer

(STAT News) – Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pediatric, Pharma



 
 

March 11, 2024

Setbacks Reset Views on Highly Touted Alzheimer’s and ALS Drugs

(Axios) – A pair of setbacks to drugs for Alzheimer’s disease and ALS on Friday served as another reminder that widely touted treatments for desperate patients aren’t necessarily a sure thing. Why it matters: Drugs are increasingly judged on the … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Informed Consent, Neuroethics, News, Pharma



 
 

March 11, 2024

Overdose or Poisoning? A New Debate Over What to Call a Drug Death.

(New York Times) – As millions of fentanyl-tainted pills inundate the United States masquerading as common medications, grief-scarred families have been pressing for a change in the language used to describe drug deaths. They want public health leaders, prosecutors and … Read More

Posted by Bioethics Pundit

Posted in Informed Consent, Mental Health, Neuroethics, News, Pharma, Public Health



 
 

March 8, 2024

Obesity Drug Wegovy Is Approved to Cut Heart Attack and Stroke Risk in Overweight Patients

(ABC News) – The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pharma, Public Health



 
 

March 8, 2024

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn from the Market

(New York Times) – One of the few treatments the Food and Drug Administration has approved for amyotrophic lateral sclerosis has failed a large clinical trial, and its manufacturer said Friday that it was considering whether to withdraw it from … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Informed Consent, Neuroethics, News, Pharma



 
 

March 8, 2024

Ahead of Oscars, Maker of Blockbuster Weight Loss Drug Urges Against ‘Vanity’ Use in New Ad Campaign

(CNN) – “When I look around this room, I can’t help but wonder,” Academy Awards host Jimmy Kimmel joked at last year’s ceremony. “Is Ozempic right for me?” Celebrities’ use of a type 2 diabetes drug to lose weight had … Read More

Posted by Bioethics Pundit

Posted in highlights, Human Enhancement, Informed Consent, News, Pharma



 
 

March 7, 2024

Weight-Loss Drugs Like Wegovy Are Meant for Long-Term Use. What Happens If You Stop?

(NBC News) – Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry, rightly, that they’ll regain weight and … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, Neuroethics, News, Pharma



 
 

March 7, 2024

E.R. Visits Quadruple for Children Accidentally Eating Melatonin

(Wall Street Journal) – More parents with young children are taking melatonin to sleep. And some of them are going to the emergency room after their children took melatonin accidentally. The number of children who visited emergency rooms for unsupervised … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pediatric, Pharma



 
 

March 7, 2024

RSV Monoclonal Beyfortus Was 90% Effective at Preventing Hospitalizations in Children This Winter: CDC

(STAT News) – A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at preventing little children from being hospitalized with RSV, according to new data from the first season it was in use. (Read More)

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pediatric, Pharma, Public Health



 
 

March 7, 2024

The Cystic-Fibrosis Breakthrough That Changed Everything

(The Atlantic) – The disease once guaranteed an early death—but a new treatment has given many patients a chance to live decades longer than expected. What do they do now? After a year on Trikafta, Jenny told Teresa something that … Read More

Posted by Bioethics Pundit

Posted in Biotech, Clinical / Medical, highlights, Mental Health, News, Pharma



 
 

March 7, 2024

A Weight Loss Drug More Powerful Than Ozempic Has Novo Nordisk Stock at a Record High

(Quartz) – Novo Nordisk told investors that an early-stage drug trial found that an oral version of the drug amycretin leads to users losing 13% of their body weight after 12 weeks of treatment. Novo Nordisk stock was up more … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma



 
 

March 7, 2024

When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher

(KFF Health News) – Whether on Facebook or Instagram, patients and clinics alike are giddy about the possibilities. But it is a drug that can be abused and can be deadly. Thus, ketamine is the latest challenge for Meta, the … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Emerging Technologies, highlights, Informed Consent, News, Pharma



 
 

March 6, 2024

World Bank, Gates, UN Pledge Close to $600 Million to End Cervical Cancer

(Reuters) – Global health donors pledged nearly $600 million towards eliminating cervical cancer on Tuesday, at the first global forum dedicated to fighting the disease. The World Bank, the Bill & Melinda Gates Foundation and the U.N. children’s agency UNICEF … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, News, Pharma, Public Health, Women's Health



 
 

March 6, 2024

Lab Leader Pleads No Contest to Manslaughter in 2012 Michigan Meningitis Deaths

(Associated Press) – The co-founder of a specialty pharmacy that was at the center of a deadly national meningitis outbreak in 2012 pleaded no contest to involuntary manslaughter in Michigan, authorities said Tuesday. (Read More)

Posted by Bioethics Pundit

Posted in Clinical / Medical, News, Pharma



 
 

March 6, 2024

A 62-Year-Old German Man Got 217 Covid Shots–and Was Totally Fine

(Wired) – A 62-year-old man in Germany decided to get 217 Covid-19 vaccinations over the course of 29 months —for “private reasons.” But, somewhat surprisingly, he doesn’t seem to have suffered any ill effects from the excessive immunization, according to … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Covid-19, highlights, News, Pharma, Public Health



 
 

March 6, 2024

FDA Advisory Panel Recommends Revision to Flu Vaccine

(Axios) – An FDA advisory panel on Tuesday voted unanimously for a recommendation that the agency adopt a modified flu vaccine for next fall that could make it easier for manufacturers to increase supplies. The big picture: The panel’s recommendation … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma, Public Health



 
 

March 5, 2024

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

(New York Times) – Ibogaine, a formidable psychedelic made from the root of a shrub native to Central Africa, is not for the timid. It unleashes a harrowing trip that can last more than 24 hours, and the drug can … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, Mental Health, Neuroethics, News, Pharma, Research Ethics



 
 

March 5, 2024

Your Child’s Medicine Probably Wasn’t Fully Vetted. Here’s Why.

(Undark) – When drugs get approved, it’s usually on the basis of how they function in adults. This holds true for nearly all conditions, including mental health disorders, cancer, and rare diseases. As a result, children are usually prescribed medication … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pediatric, Pharma, Research Ethics



 
 

March 5, 2024

The Science Behind Ozempic Was Wrong

(The Atlantic) – The drugs work as intended: as powerful modulators of appetite. But at the same time that they have become massive successes, the original science that underpinned their development has fallen apart. The fact that they worked was … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, Neuroethics, News, Pharma



 
 

March 5, 2024

How the U.S. Is Sabotaging Its Best Tools to Prevent Deaths in the Opioid Epidemic

(STAT News) – The opioid overdose epidemic has burned through the U.S. for nearly 30 years. Yet for all that time, the country has had tools that are highly effective at preventing overdose deaths: methadone and buprenorphine. These medicines are … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Mental Health, Neuroethics, News, Pharma, Public Health



 
 

March 5, 2024

Patients Lose Access to Weight-Loss Drugs as Employers Stop Coverage

(Wall Street Journal) – Employers that embraced paying for weight-loss drugs are now reckoning with the high costs, forcing growing numbers to dial back or cut off their reimbursement because they can’t afford it. The companies are putting in place … Read More

Posted by Bioethics Pundit

Posted in Healthcare, News, Pharma, Public Health



 
 
Older posts Newer posts
  • Recent News
  • Trending
  • 11/13/2026Younger workers are hiding AI usage from bosses as they try to hold on to jobs
  • 11/13/2026He learned he has 35 siblings. Here’s how he aired his family secret.
  • 11/13/2026Why Is It So Hard to Teach A.I. Agents to Behave? Researchers Have a Theory.
  • 11/13/2026The People Working to Keep Their AI Partners Alive
  • 11/13/2026Synchron Pauses Trials of Its Brain Implant Due to Performance Issues
More News
    • Artificial Intelligence
    • Biotech
    • Clinical / Medical
    • Cloning
    • Covid-19
    • Culture
    • Disability Ethics
    • Disaster Ethics
    • Education
    • Emerging Technologies
    • Employment / Fellowships / Internships
    • End of Life
    • Eugenics
    • Euthanasia / Suicide
    • Genetic Ethics
    • Geriatric & Aging
    • Global Bioethics
    • Healthcare
    • Human Dignity
    • Human Enhancement
      • Transhumanism
    • Informed Consent
    • Journal Articles
    • Medical Tourism
    • Mental Health
    • Multimedia Resources
    • Nanotechnology
    • Neuroethics
    • News
      • Op-Ed
    • Nursing
    • Organ Donation / Transplantation
    • Pediatric
    • Pharma
    • Public Health
    • Public Policy
    • Reproductive Ethics
    • Research Ethics
    • Reviews
      • Books
      • Movies
    • Stem Cell Research
    • Synthetic Biology
    • Women's Health
    Ad
    bioethics.com
    • Home
    • About
    • Events
    • Contact
    • Advertising

    bioethics.com © 2002–Present by CBHD is licensed under CC BY-NC-ND 4.0

    • Twitter
    • RSS

    A Project Of The Center for Bioethics & Human Dignity